MultiStem

Related by string. * * MultiStem ® . developing MultiStem . developing MultiStem r *

Related by context. All words. (Click for frequent words.) 67 Cethrin 66 PLX cells 65 Azedra 65 MYDICAR ® 64 Chrysalin 64 GGF2 64 TG# [003] 63 TB4 63 Traficet EN 63 Symadex 63 Serdaxin 63 NP2 Enkephalin 63 rilonacept 62 VAPRISOL 62 PEG SN# 62 Prochymal 62 C1 INH 62 ProSavin 62 PROMACTA 62 CGEN # 62 Bendavia 62 Viprinex 62 Amplimexon 61 Archexin 61 Revimmune 61 GRNCM1 61 HuMax CD# 61 GRNOPC1 61 HuMax EGFr 61 TriRima 61 cilengitide 61 HQK 61 PXD# 61 eculizumab 61 JAK inhibitors 61 tafamidis 61 alagebrium 61 ENMD # 61 APOPTONE 61 Nanobody 61 MGCD# [001] 61 ISIS # 61 Triolex 60 ZFP TF 60 Cardio Vascu Grow 60 KALBITOR 60 XmAb# 60 tgAAC# 60 OHR/AVR# 60 OncoVEX 60 Amigal 60 teduglutide 60 SomatoKine 60 PROCHYMAL 60 TRIOLEX 60 OXi# 60 CCX# 60 JAK inhibitor 60 Tβ4 60 ganetespib 60 BHT DNA 60 #ME# 60 PRT# 60 Generx 60 ELND# 60 NTx TM -# 60 rNAPc2 60 Fibrillex TM 60 otelixizumab 60 BAY #-# 60 LymphoStat B 60 samalizumab 60 Provacel 59 juvenile chondrocytes 59 methylnaltrexone 59 Excellarate 59 Mipomersen 59 lomitapide 59 bafetinib 59 pralatrexate 59 investigational monoclonal antibody 59 ESBA# 59 preclinical studies 59 dexanabinol 59 NTDDS 59 Cotara 59 HuCNS SC cells 59 Bezielle 59 vidofludimus 59 systemically administered 59 MYDICAR 59 ataluren 59 MNTX 59 plasma kallikrein inhibitor 59 Androxal TM 59 PEG Interferon lambda 59 KNS # 59 Oral NKTR 59 rBChE 59 HuLuc# 59 Nanobody ® 59 TYZEKA 59 Plicera 59 ACZ# 59 R#/MEM # 59 pharmacological chaperone 59 romidepsin 59 tezampanel 59 Catena ® 59 PLX PAD 59 BEXXAR 59 GATTEX 59 Sym# 59 NV1FGF 58 visilizumab 58 NU# [001] 58 PDE4 inhibitor 58 Arcalyst 58 Alocrest 58 Octreolin 58 custirsen 58 sd rxRNA 58 eltrombopag 58 NNR Therapeutics 58 Revascor TM 58 oral prodrug 58 INCB# [001] 58 urocortin 2 58 CA4P 58 IMiDs 58 Chemophase 58 Perforomist ™ Inhalation Solution 58 FOLOTYN 58 MabCampath 58 orally bioavailable 58 DP b# 58 riociguat 58 CYCLOSET 58 CINTREDEKIN BESUDOTOX 58 preclinically 58 Advexin 58 ISTODAX 58 omacetaxine 58 Carfilzomib 58 investigational humanized monoclonal antibody 58 Panzem 58 TELINTRA 58 LEUKINE 58 Factor VIIa 58 HGS ETR1 58 atacicept 58 NUVIGIL 58 acute ischemic stroke 58 Preclinical studies 58 Pimavanserin 58 SinuNase 58 CIMZIA ™ 58 Rasagiline 58 wilate ® 58 Cethrin R 58 Resten NG 58 glufosfamide 58 HuMax CD4 58 ARCALYST 58 talactoferrin 58 cobiprostone 58 cannabinor 58 trodusquemine 58 Panzem R 58 Androxal 58 Azixa 58 favorable pharmacokinetic profile 58 adult mesenchymal stem 57 PEGylated 57 ANG# 57 Omacetaxine 57 Nanobodies 57 cancer immunotherapies 57 Vilazodone 57 PSMA ADC 57 pomalidomide 57 GLYX 57 GRN# 57 ANAVEX #-# [001] 57 INT# [002] 57 EP #R 57 Radilex 57 Desmoteplase 57 recurrent glioma 57 ReN# 57 RDEA# 57 Marqibo 57 elotuzumab 57 rhIGF-I/rhIGFBP-3 57 AZX# 57 Soliris eculizumab 57 pradefovir 57 elacytarabine 57 CEQ# 57 TORISEL 57 Lisofylline 57 YONDELIS 57 Icatibant 57 TREANDA 57 TACI Ig 57 zileuton 57 Tyrima 57 HspE7 57 Anturol 57 AGGRASTAT ® 57 OncoVEX GM CSF 57 imetelstat 57 ASONEP 57 forodesine 57 proteasome inhibitor 57 TRV# [001] 57 Nasulin 57 HCD# [002] 57 Homspera 57 DXL# 57 Xanafide 57 anticancer therapies 57 investigational compounds 57 PRISTIQ 57 NGX# 57 RLY# 57 IRX 2 57 Tß4 57 allogeneic cell 57 Valortim 57 Dapagliflozin 57 subcutaneous formulation 57 oral antiviral 57 CCR9 antagonist 57 rFIXFc 57 uricase 57 RSD# 57 alfimeprase 57 eniluracil 57 Aurexis 57 PS# [001] 57 novel peptide 57 milatuzumab 57 VSELs 57 MACUGEN 57 remyelination 57 LY# [003] 57 AMEVIVE 57 synthetic retinoid 57 huC# DM4 57 CR# vcMMAE 57 decitabine 57 CRLX# 57 PHX# 57 Virulizin ® 57 Interferon alpha 57 angiogenesis inhibitor 57 PLK1 SNALP 57 CIMZIA TM 57 regadenoson 57 deforolimus 57 Cimzia ® certolizumab pegol 57 ALN TTR# 57 XP# XP# 57 allogeneic 57 Aviptadil 57 MEK inhibitors 57 Trofex 57 VA# [002] 57 MAGE A3 ASCI 57 GFT# 56 R roscovitine 56 Anthim 56 Dacogen injection 56 mertansine 56 IDX# 56 TKM ApoB 56 liposomal formulation 56 Hemospan 56 SARMs 56 picoplatin 56 Plasmin 56 INCB# [002] 56 anticancer agent 56 brivaracetam 56 Lixivaptan 56 reslizumab 56 preclinical efficacy 56 CTLA4 Ig 56 Vidofludimus 56 ORENCIA R 56 MLN# 56 CoFactor 56 Reolysin 56 phase IIa clinical 56 KRN# 56 blinatumomab 56 ularitide 56 favorable tolerability 56 ZOLINZA 56 Allovectin 7 R 56 Protexia R 56 amrubicin 56 CBLC# 56 GALNS 56 S/GSK# 56 bardoxolone methyl 56 RNAi therapeutic 56 daclizumab 56 Cimzia R 56 LEVADEX 56 AeroLEF TM 56 NexACT 56 Ataluren 56 nanopharmaceutical 56 epothilones 56 GAMMAGARD 56 PI3K/Akt pathway inhibitor 56 Proxinium TM 56 AAV vector 56 TOLAMBA 56 fenofibric acid 56 LEX System 56 ICA # 56 selective androgen receptor modulator 56 Imprime PGG 56 metaglidasen 56 autologous bone marrow 56 MAXY G# 56 HepDirect technology 56 CYT# 56 NLX P# 56 omecamtiv mecarbil 56 squalamine 56 Exherin TM 56 MyVax R 56 adenovector 56 anticoagulant reversing agent 56 BrachySil TM 56 Navelbine ® 56 Golimumab 56 TELCYTA 56 omega interferon 56 varespladib 56 JAK2 inhibitors 56 DDP# 56 IMA# 56 antitumor activity 56 HCV protease inhibitors 56 Simulect 56 refractory gout 56 DAVANAT 56 CERE 56 GED aPC 56 ZYBRESTAT 56 Arimoclomol 56 neuroprotective properties 56 tolerability profiles 56 SNT MC# 56 rFVIIIFc 56 Relivar 56 AGGRASTAT R 56 Betrixaban 56 obatoclax 56 XL# [003] 56 Cand5 56 Troxatyl 56 Onconase 56 PRX# 56 Vivaglobin 56 NEUMUNE 56 Synavive 56 therapeutic monoclonal antibody 56 incyclinide 56 EOquin TM 56 REG1 56 laquinimod 56 Methylnaltrexone 56 Fx #A 56 human neural stem 56 tamibarotene 56 Hsp# inhibitor 55 immune modulatory 55 LT NS# 55 elagolix 55 oral gallium 55 PrevOnco ™ 55 Targretin 55 Nuvion 55 novel oral anticoagulant 55 MGd 55 ALN VSP 55 CIPN 55 menadione 55 tolvaptan 55 ATL# [002] 55 Alfimeprase 55 Arikace 55 GRNVAC1 55 Prestara 55 pseudobulbar affect PBA 55 DU #b 55 ALN RSV# 55 ACTEMRA 55 enzastaurin 55 GSK# [001] 55 Panzem R NCD 55 Amrubicin 55 DCVax ® 55 OMS#HP 55 ImmunoVEX HSV2 55 IL# PE#QQR 55 Campath ® 55 etanercept 55 rhThrombin 55 Daclizumab 55 JANUVIA 55 Phase 2a trial 55 cartilage regeneration 55 Firazyr 55 thymalfasin 55 Teriflunomide 55 iroxanadine 55 ALGRX 55 romiplostim 55 #beta HSD1 55 Exelixis compounds 55 ARIKACE 55 Enzyme Replacement Therapy 55 Trastuzumab 55 Neurodex 55 investigational drug 55 ONTAK 55 CANCIDAS 55 EndoTAG TM 55 Tolvaptan 55 JAK3 55 davunetide 55 Adentri 55 TYKERB 55 BENLYSTA ® 55 ecallantide 55 deacetylase inhibitors 55 QLT# 55 AVN# [001] 55 calcitonin 55 refractory angina 55 Behcet uveitis 55 Numax 55 vorinostat 55 anakinra 55 Litx 55 Vicinium TM 55 AQ4N 55 Zelapar 55 Tesetaxel 55 drug zotarolimus 55 FOLOTYN ® 55 HuCNS SC 55 Xcellerated T Cells 55 TH# [003] 55 anti leukemic 55 muraglitazar 55 efficacy tolerability 55 preclinical models 55 Leukine 55 MAP# 55 CORT # 55 rHuPH# 55 ibudilast 55 anti fibrotic 55 Altastaph 55 anticancer activity 55 Cethromycin 55 ADVEXIN 55 SGS# 55 ganaxolone 55 baminercept 55 Capesaris 55 volociximab 55 desmoteplase 55 brostallicin 55 EndoTAG TM -1 55 Ilaris 55 torezolid phosphate 55 #I TM# 55 Microplasmin 55 Excellagen 55 tesetaxel 55 PRTX 55 CINQUIL 55 bicifadine 55 SIR Spheres 55 THR beta agonist 55 p# inhibitors 55 radiolabeled TM# 55 iSONEP 55 Phenoptin 55 Bortezomib 55 Restanza 55 NeuroFlo 55 investigational compound 55 ZEVALIN 55 immunomodulatory 55 Anticalin R 55 Zerenex 55 neuroprotection 55 neuroprotective 55 P#X# 55 Romidepsin 55 PRX # 55 ALN TTR 55 TBC# 55 QuadraSphere 55 RG# [001] 55 ophthalmology oncology 55 Eculizumab 55 Gemzar ® 55 Fampridine SR 55 AP# [003] 55 ramelteon 55 Toraymyxin TM 55 liprotamase 55 axitinib 55 Aerosurf 55 cyclophilin inhibitors 55 lumiliximab 55 Gattex 55 SNALP technology 55 Factor IX 55 Protectan CBLB# 55 darapladib 55 Neuradiab 55 lintuzumab 55 biodegradable implant 55 Zoraxel 55 Zolinza 55 REMICADE ® 55 Apoptone 55 posaconazole 55 AZILECT ® 54 bazedoxifene 54 Ceflatonin R 54 SCH # 54 ONCONASE 54 cortical stimulation therapy 54 tanespimycin 54 L BLP# 54 Ceflatonin 54 KL4 surfactant 54 SERMs 54 PORxin TM 54 Dasatinib 54 hypervascular tumors 54 VDAs 54 Cell Pouch System 54 LentiVector technology 54 RAPTIVA 54 proteasome inhibitor bortezomib 54 selective modulator 54 erythropoietic 54 SRT# [003] 54 UVIDEM 54 Plenaxis TM 54 pharmacokinetic properties 54 Ophena TM 54 Cx# [002] 54 SNT-MC#/idebenone 54 Hyphanox 54 AAV vectors 54 CDK inhibitors 54 delafloxacin 54 neratinib 54 teriflunomide 54 icatibant 54 Bioral ® 54 maribavir 54 rindopepimut 54 Ebola SNALP 54 anticancer compound 54 TNF alpha antagonist 54 QNEXA 54 efalizumab 54 Phase 2a 54 cortical stimulation 54 plasma kallikrein 54 multitargeted 54 Noxafil 54 MyoCell 54 pharmacokinetic PK study 54 bevasiranib 54 GLPG# 54 Aflibercept 54 sitaxsentan 54 mTOR inhibitors 54 Vidaza azacitidine 54 EVIZON 54 vivo validation 54 insulin sensitizers 54 NEUGENE 54 CD# monoclonal antibody 54 BioVant 54 Personalized Immunotherapy 54 belinostat 54 gefitinib Iressa 54 HCV protease inhibitor 54 thetreatment 54 Smac mimetics 54 Vandetanib 54 Nexavar ® 54 metreleptin 54 Tarceva TM 54 ocrelizumab 54 sargramostim 54 CB1 antagonists 54 Genz # 54 Vernakalant 54 anti CD3 antibody 54 PREOS 54 oritavancin 54 MTP inhibitor 54 Cerashield 54 CobaCyte 54 PD LID 54 Debio 54 Bioral 54 calcineurin inhibitor 54 teplizumab 54 biologic therapy 54 vProtect TM Luminal Shield 54 anti amnesic 54 Cannabinor 54 Emezine 54 UPLYSO 54 topical formulations 54 PEGylated interferon beta 1a 54 CD# antibody [001] 54 tiapamil 54 nalbuphine ER 54 pharmacodynamic properties 54 CRx 54 perifosine 54 Privigen 54 denufosol 54 VitiGam 54 Clonicel 54 tolerability profile 54 gabapentin enacarbil 54 resolvin 54 targeted antifolate 54 mipomersen 54 Celator 54 davunetide intranasal AL 54 selective inhibition 54 Azedra TM 54 Inhalation Solution 54 sorafenib tablets 54 CTAP# Capsules 54 TriGrid ™ 54 Locteron 54 vilazodone 54 histone deacetylase inhibitor 54 dimebon 54 neurotrophic 54 AAV2 54 Zingo TM 54 Rebif ® 54 antifibrotic 54 Telintra 54 orally administered inhibitor 54 Saforis 54 ProMune 54 pharmacodynamic profile 54 AEOL # 54 Ofatumumab 54 ELADUR 54 ABILIFY ® 54 prostone 54 ARIKACE ™ 54 TRO# 54 Carticel 54 GRN#L 54 Alpharadin 54 INCB# [003] 54 ostarine 54 AAGP ™ 54 Hsp# inhibition 54 dacetuzumab 54 Glufosfamide 54 pharmacodynamic 54 Tarvacin 54 adipose derived stem cells 54 IMGN# 54 myoblast therapy 54 Anticalins 54 kidney urologic 54 Phase 1b trial 54 blood clot dissolver 54 nonclinical studies 54 albinterferon alfa 2b 54 CK # 54 lesinurad 54 zileuton CR 54 ofatumumab 54 MAXY VII 54 Rescula 54 Cinryze 54 DOS# 54 DexaSite 54 blinded randomized placebo controlled 54 Cinryze TM 54 ON #.Na 54 nitazoxanide 54 Aplidin 54 MP4OX 54 EDEMA3 54 BiTE 54 CBLB# 54 pan HDAC inhibitor 54 Doxil 54 Perifosine 54 NOXAFIL 54 lupus nephritis 54 PI3K inhibitor 54 RhuDex 54 docetaxel Taxotere ® 54 AEGR 54 BRIM2 54 Gleevec resistant 54 dexpramipexole 54 Alequel ™ 54 vascular disrupting agents 54 tesmilifene 54 Syncria 54 AZILECT R 54 veltuzumab 54 RhuDex ® 54 antiangiogenic activity 54 MYO VAD 54 adenosine A2A 54 Talabostat 54 ISENTRESS 54 lenalidomide Revlimid R 54 placebo controlled clinical 54 Mylotarg 53 proteasome inhibitors 53 ELACYT 53 Alzhemed TM 53 bavituximab 53 Sandostatin LAR 53 plerixafor 53 hematological cancers 53 thrombin inhibitor 53 LC#m# 53 Stedivaze 53 daptomycin 53 ALKS 53 LymphoStat B TM 53 sodium thiosulfate STS 53 CXB# 53 Actilon 53 alvespimycin 53 Andara TM OFS 53 Cytolin ® 53 AzaSite Plus 53 Gabapentin GR 53 Combidex 53 #D#C# 53 recombinant factor VIIa 53 BYDUREON 53 mTOR inhibitor 53 VEGF Trap 53 Elesclomol 53 Anavex #-# 53 Phase IIB 53 acadesine 53 Prodarsan ® 53 AZD# 53 hA# 53 HoFH 53 DCVax R 53 fibrotic disease 53 humanized anti 53 Tamibarotene 53 Entereg R 53 peripherally acting 53 COMT inhibitors 53 renin inhibitors 53 HGS# 53 noninfectious uveitis 53 immunomodulator 53 temsirolimus 53 azacitidine 53 HUCB cells 53 ATHX 53 tramiprosate 53 ATL# [001] 53 PSN# [001] 53 calcineurin inhibitors 53 depsipeptide 53 Tarvacin TM 53 VPRIV 53 opioid induced bowel dysfunction 53 Tovaxin 53 CYC# 53 antisense drugs 53 CaPre TM 53 autologous cell 53 novel immunomodulatory 53 Pertuzumab 53 GvHD 53 synthetic peptide 53 Cleviprex TM clevidipine 53 Epratuzumab 53 Ocrelizumab 53 xanthine oxidase inhibitor 53 CORLUX 53 phase IIb clinical 53 ALD# 53 Promacta 53 chemotherapeutic drug 53 Unit Dose Budesonide 53 Bicifadine 53 Intermezzo R 53 orally dosed 53 thrombolytics 53 mGluR2 NAM 53 FTY# 53 tranilast 53 Tavocept 53 AZILECT 53 MET amplification 53 EGS# 53 epratuzumab 53 Enzastaurin 53 HYC# 53 talabostat 53 Cimzia TM 53 isoform selective 53 preclinical 53 histone deacetylase HDAC inhibitor 53 Radezolid 53 antihypertensive agents 53 CD# CEA 53 Rasilez Tekturna 53 hGH CTP 53 ulimorelin 53 IPLEX 53 Zelrix 53 docetaxel Taxotere R 53 heterozygous FH 53 Anticalin ® 53 Rituximab 53 OMNARIS HFA 53 Cancidas 53 Corgentin 53 mesenchymal stem cells MSCs 53 IAP inhibitors 53 SANVAR 53 oral talactoferrin 53 BNC# 53 PDE4 inhibitors 53 DR Cysteamine 53 Sudhir Agrawal D.Phil 53 EVIZON TM 53 Evoltra 53 immune modulation 53 Homspera TM 53 prodrug 53 gastrointestinal stromal tumors GIST 53 immunosuppressive 53 AMPAKINE 53 AMD# [003] 53 anticancer agents 53 solithromycin 53 motesanib 53 CB2 selective receptor agonist 53 FavId 53 Teriparatide 53 lapatinib Tykerb 53 GORE TAG Device 53 ATL/TV# 53 Urocidin 53 JAK1 53 hESC derived 53 Umbilical cord stem cells 53 hypophosphatasia 53 entinostat 53 Viprinex TM 53 Sapacitabine 53 INGN 53 Neulasta ® 53 oral bioavailability 53 ALN HTT 53 thalidomide Thalomid 53 vandetanib 53 AMPAKINE compounds 53 MyVax ® 53 tolevamer 53 Zenvia ™ 53 Dr. Aiping Young 53 SinuNase TM 53 XL# XL# 53 tasimelteon 53 NEUGENE antisense 53 dirucotide 53 Vitaxin 53 Curaxin 53 eprotirome 53 bevacizumab Avastin 53 sapacitabine 53 receptor inhibitor 53 Merci Retrieval System 53 resolvins 53 G CSF 53 REMINYL ® 53 Zalypsis 53 pharmacokinetic profile 53 tocilizumab 53 synthetic siRNA 53 RGB # 53 MEK inhibitor 53 chimeric monoclonal antibody 53 IMP# 53 XmAb 53 interferon beta 1b 53 OPAXIO 53 Transdel TM 53 6R BH4 53 MDV# 53 intranasal formulation 53 alvimopan 53 MyoCell R 53 DAVANAT ® 53 Clolar ® 53 IGIV 53 velafermin 53 Nebido 53 hematologic disorders 53 Lubiprostone 53 LEVADEX ™ 53 CIMZIA TM certolizumab pegol 53 velafermin belinostat 53 liposomal 53 lipid lowering therapies 53 Aganocide 53 Ecallantide 53 edifoligide 53 Raptiva ® 53 Myoblast Program 53 ruboxistaurin 53 anticancer therapy 53 bioartificial liver 53 MEK inhibitor RDEA# 53 pertuzumab 53 EZN 53 Quinamed 53 PEGPH# 53 rasagiline tablets 53 intranasal delivery 53 Atiprimod 53 Ozurdex 53 recombinant albumin 53 Torisel 53 investigational therapies 53 Iloperidone 53 Guanilib 53 postoperative ileus POI 53 ANAVEX #-# [003] 53 INC# 53 Arranon 53 rhC1INH 53 GAP #B# 53 radiation sensitizer 53 pharmacokinetic profiles 53 effector functions 53 immune modulator 53 linaclotide 53 monoclonal antibody 53 cMET 53 Kuvan 53 NurOwn ™ 53 Oxiplex 53 oral rivaroxaban 53 cells hESCs 53 Selective Electrochemical Tumor Ablation 53 either acutely decompensated 53 Fibrin Pad 53 ENBREL 53 relapsed multiple myeloma 53 schizophrenia CIAS 53 Frova ® 52 elesclomol 52 Posiphen 52 Treximet 52 Fabry Disease 52 Factor Xa inhibitor 52 fosbretabulin 52 sodium glucose cotransporter

Back to home page